{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:01:22Z","timestamp":1785855682836,"version":"3.56.0"},"reference-count":57,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2016.0301","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:27:14Z","timestamp":1525238834000},"source":"Crossref","is-referenced-by-count":34,"title":["Alcohol Dependence and Harmful Use of Alcohol: Diagnosis and Treatment Options"],"prefix":"10.3238","author":[{"given":"Anil","family":"Batra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"key":"10.3238\/arztebl.2016.0301_ref1","doi-asserted-by":"crossref","unstructured":"Mann K, Hoch E, Batra A: S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener St\u00f6rungen. Heidelberg: Springer 2015.","DOI":"10.1007\/978-3-662-47086-2"},{"key":"10.3238\/arztebl.2016.0301_ref2","doi-asserted-by":"crossref","unstructured":"Rocco A, Compare D, Angrisani D, Sanduzzi Zamparelli M, Nardone G: Alcoholic disease: liver and beyond. World J Gastroenterol 2014, 20: 14652\u20139","DOI":"10.3748\/wjg.v20.i40.14652"},{"key":"10.3238\/arztebl.2016.0301_ref3","doi-asserted-by":"crossref","unstructured":"Mukamal KJ, Jadhav PP, D\u2019Agostino RB, et al.: Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort. Circulation 2001, 104: 1367\u201373","DOI":"10.1161\/hc3701.096067"},{"key":"10.3238\/arztebl.2016.0301_ref4","doi-asserted-by":"crossref","unstructured":"Knott CS, Coombs N, Stamatakis E, Biddulph JP: All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts. BMJ 2015; 350: h 384","DOI":"10.1136\/bmj.h384"},{"key":"10.3238\/arztebl.2016.0301_ref5","doi-asserted-by":"crossref","unstructured":"Landgraf MN, Nothaber M, Kopp IB, Heinen F: Clinical practice guideline: The diagnosis of fetal alcohol syndrome. Dtsch Arztebl Int 2013; 110: 703\u201310","DOI":"10.3238\/arztebl.2013.0703"},{"key":"10.3238\/arztebl.2016.0301_ref6","unstructured":"Statistisches Bundesamt: www.destatis.de\/DE\/ZahlenFakten\/GesellschaftStaat\/Gesundheit\/Krankenhaeuser\/Tabellen\/DiagnosenInsgesamt.html;jsessionid=BC1BFC5DDBFD748FC963F019695C9656.cae3 (last accessed on 13 November 2015)."},{"key":"10.3238\/arztebl.2016.0301_ref7","doi-asserted-by":"crossref","unstructured":"Nath B, Li Y, Carroll JE, Szabo G, Tseng JF, Shah SA: Alcohol exposure as a risk factor for adverse outcomes in elective surgery. J Gastrointest Surg 2010; 14: 1732\u201341","DOI":"10.1007\/s11605-010-1350-4"},{"key":"10.3238\/arztebl.2016.0301_ref8","doi-asserted-by":"crossref","unstructured":"R\u00fcther T, Bobes J, De Hert M, et al.: EPA guidance on tobacco dependence and strategies for smoking cessation in people with mental illness. Eur Psychiatry 2014; 29: 65\u201382","DOI":"10.1016\/j.eurpsy.2013.11.002"},{"key":"10.3238\/arztebl.2016.0301_ref9","doi-asserted-by":"crossref","unstructured":"Di Chiara G, Imperato A: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 1988; 85: 5274\u20138","DOI":"10.1073\/pnas.85.14.5274"},{"key":"10.3238\/arztebl.2016.0301_ref10","doi-asserted-by":"crossref","unstructured":"Duncan J, Johnson S, Ou XM: Monoamine oxidases in major depressive disorder and alcoholism. Drug Discov Ther 2012; 6: 112\u201322","DOI":"10.5582\/ddt.2012.v6.3.112"},{"key":"10.3238\/arztebl.2016.0301_ref11","doi-asserted-by":"crossref","unstructured":"Ho PS, Shih MC, Ma KH, et al.: Availability of the serotonin transporter in patients with alcohol dependence. World J Biol Psychiatry 2011; 12: 134\u201342","DOI":"10.3109\/15622975.2010.503813"},{"key":"10.3238\/arztebl.2016.0301_ref12","doi-asserted-by":"crossref","unstructured":"Heinz AJ, Beck A, Meyer-Lindenberg A, Sterzer P, Heinz A: Cognitive and neurobiological mechanisms of alcohol-related aggression. Nature Reviews Neuroscience 2011; 12: 400\u201313","DOI":"10.1038\/nrn3042"},{"key":"10.3238\/arztebl.2016.0301_ref13","doi-asserted-by":"crossref","unstructured":"Hannuksela ML, Liisanantti MK, Nissinen AET, Savolainen MJT: Biochemical markers of alcoholism. Clin Chem Lab Med 2007; 45: 953\u201361","DOI":"10.1515\/CCLM.2007.190"},{"key":"10.3238\/arztebl.2016.0301_ref14","doi-asserted-by":"crossref","unstructured":"Aradottir S, Asanovska G, Gjerss S, Hansson P, Alling C: Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol and alcoholism 2006; 41: 431\u20137","DOI":"10.1093\/alcalc\/agl027"},{"key":"10.3238\/arztebl.2016.0301_ref15","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V.: Alkoholbezogene St\u00f6rungen: Screening, Diagnose und Behandlung. AWMF S3 Leitlinie. www.awmf.org\/uploads\/tx_szleitlinien\/076\u2013001l_S3-Leitlinie_Alkohol_2015\u201304.html (last accessed on 13 November 2015)."},{"key":"10.3238\/arztebl.2016.0301_ref16","doi-asserted-by":"crossref","unstructured":"Norcross JC, Wampold BE: Evidence-based therapy relationships: research conclusions and clinical practices. Psychotherapy (Chic) 2011; 48: 98\u2013102","DOI":"10.1037\/a0022161"},{"key":"10.3238\/arztebl.2016.0301_ref17","doi-asserted-by":"crossref","unstructured":"Erwin WE, Williams DB, Speir WA: Delirium tremens. South Med J 1998; 91: 425\u201332","DOI":"10.1097\/00007611-199805000-00003"},{"key":"10.3238\/arztebl.2016.0301_ref18","unstructured":"Zilker T: Alkoholentzugssyndrom und Delirium tremens. MMW 1999; 141: 26\u201330."},{"key":"10.3238\/arztebl.2016.0301_ref19","doi-asserted-by":"crossref","unstructured":"Hillbom M, Pieninkeroinen I, Leone M: Seizures in alcohol-dependent patients: epidemiology, pathophysiology and management. CNS Drugs 2003; 17:1013\u201330","DOI":"10.2165\/00023210-200317140-00002"},{"key":"10.3238\/arztebl.2016.0301_ref20","doi-asserted-by":"crossref","unstructured":"Lutz U, Batra A: Diagnostik und Therapie des Alkoholentzugssyndroms: Fokus auf Delirium tremens und Entzugskrampfanfall. Psych Praxis 2010; 37: 271\u20138","DOI":"10.1055\/s-0030-1248443"},{"key":"10.3238\/arztebl.2016.0301_ref21","doi-asserted-by":"crossref","unstructured":"Boothby LA, Doering RL: Acamprosate for the treatment of alcohol dependence. Clin Ther 2005; 27: 695\u201314","DOI":"10.1016\/j.clinthera.2005.06.015"},{"key":"10.3238\/arztebl.2016.0301_ref22","doi-asserted-by":"crossref","unstructured":"Walter M, D\u00fcrsteler KM, Petitjean SA, Wiesbeck GA, Euler S, Sollberger D: Psychosocial treatment of addictive disorders\u2014an overview of psychotherapeutic options and their efficacy. Fortschr Neurol Psychiatr 2015; 83: 201\u201310","DOI":"10.1055\/s-0034-1399338"},{"key":"10.3238\/arztebl.2016.0301_ref23","doi-asserted-by":"crossref","unstructured":"Mann K, Lehert P, Morgan MY: The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 2004; 28: 51\u201363","DOI":"10.1097\/01.ALC.0000108656.81563.05"},{"key":"10.3238\/arztebl.2016.0301_ref24","doi-asserted-by":"crossref","unstructured":"R\u00f6sner S, Hackl-Herrwerth A, Leucht S, Vecchi S, Srisurapanont M, Soyka M: Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 2010; (12): CD001867","DOI":"10.1002\/14651858.CD001867.pub3"},{"key":"10.3238\/arztebl.2016.0301_ref25","doi-asserted-by":"crossref","unstructured":"Jonas DE, Arnick HR, Feltner C, et al.: Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA. 2014; 311: 1889\u2013900","DOI":"10.1001\/jama.2014.3628"},{"key":"10.3238\/arztebl.2016.0301_ref26","doi-asserted-by":"crossref","unstructured":"Mann K, Lem\u00e9nager T, Hoffmann S, et al.: Results of a double-blind placebo controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addict Biol 2013; 18: 937\u201346","DOI":"10.1111\/adb.12012"},{"key":"10.3238\/arztebl.2016.0301_ref27","doi-asserted-by":"crossref","unstructured":"Krampe H, Ehrenreich H: Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des 2010; 16: 2076\u201390","DOI":"10.2174\/138161210791516431"},{"key":"10.3238\/arztebl.2016.0301_ref28","doi-asserted-by":"crossref","unstructured":"Niederhofer H, Staffen W: Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. Drug Alcohol Rev 2003; 22: 295\u20137","DOI":"10.1080\/0959523031000154436"},{"key":"10.3238\/arztebl.2016.0301_ref29","doi-asserted-by":"crossref","unstructured":"Krampe H, Stawicki S, Wagner T: Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome. Alcohol Clin Exp Res 2006; 30: 86\u201395","DOI":"10.1111\/j.1530-0277.2006.00013.x"},{"key":"10.3238\/arztebl.2016.0301_ref30","doi-asserted-by":"crossref","unstructured":"M\u00fcller CA, Geisel O, Pelz P: High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial. Eur Neuropsychopharmacol 2015; 8: 1167\u201377","DOI":"10.1016\/j.euroneuro.2015.04.002"},{"key":"10.3238\/arztebl.2016.0301_ref31","doi-asserted-by":"crossref","unstructured":"K\u00f6rkel J: Kontrolliertes Trinken bei Alkoholkonsumst\u00f6rungen: Eine systematische \u00dcbersicht. Sucht 2015; 6: 147\u201374","DOI":"10.1024\/0939-5911.a000367"},{"key":"10.3238\/arztebl.2016.0301_ref32","doi-asserted-by":"crossref","unstructured":"Feuerlein W, K\u00fcfner HA: prospective multicenter study of in-patient treatment for alcoholics: 18\u2013 and 48-month follow-up (Munich Evaluation for Alcoholism Treatment, MEAT). Eur Arch Psychiatry Neurol Sci 1989; 239: 144\u201357","DOI":"10.1007\/BF01739647"},{"key":"10.3238\/arztebl.2016.0301_ref33","doi-asserted-by":"crossref","unstructured":"Mann K, Sch\u00e4fer DR, L\u00e4ngle G, Ackermann K, Croissant B: The long-term course of alcoholism, 5, 10 and 16 years after treatment. Addiction 2005; 100: 797\u2013805","DOI":"10.1111\/j.1360-0443.2005.01065.x"},{"key":"10.3238\/arztebl.2016.0301_ref34","doi-asserted-by":"crossref","unstructured":"Gual A, Bravo F, Lligo\u00f1a A, Colom J: Treatment for alcohol dependence in Catalonia: health outcomes and stability of drinking patterns over 20 years in 850 patients. Alcohol and alcoholism 2009; 44: 409\u201315","DOI":"10.1093\/alcalc\/agp032"},{"key":"10.3238\/arztebl.2016.0301_ref35","doi-asserted-by":"crossref","unstructured":"Adamson SJ, Heather N, Morton V, Raistrick D: Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes. Alcohol Alcohol 2010; 45: 136\u201342","DOI":"10.1093\/alcalc\/agq005"},{"key":"10.3238\/arztebl.2016.0301_ref36","doi-asserted-by":"crossref","unstructured":"Collins SE, Malone DK, Clifasefi SL: Housing retention in single-site housing first for chronically homeless individuals with severe alcohol problems. Am J Public Health 2013; 103: 269\u201374","DOI":"10.2105\/AJPH.2013.301312"},{"key":"10.3238\/arztebl.2016.0301_ref37","doi-asserted-by":"crossref","unstructured":"Collins SE, Clifasefi SL, Dana EA, et al.: Where harm reduction meets housing first: exploring alcohol\u2019s role in a project-based housing first setting. Int J Drug Policy 2012; 23: 111\u20139","DOI":"10.1016\/j.drugpo.2011.07.010"},{"key":"10.3238\/arztebl.2016.0301_ref38","doi-asserted-by":"crossref","unstructured":"Collins SE, Grazioli VS, Torres NI, et al.: Qualitatively and quantitatively evaluating harm-reduction goal setting among chronically homeless individuals with alcohol dependence. Addict Behav 2015; 45: 184\u201390","DOI":"10.1016\/j.addbeh.2015.02.001"},{"key":"10.3238\/arztebl.2016.0301_ref39","doi-asserted-by":"crossref","unstructured":"van den Brink W, S\u00f8rensen P, Torup L, Mann K, Gual A: Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study. J Psychopharmacol 2014; 28: 733\u201344","DOI":"10.1177\/0269881114527362"},{"key":"10.3238\/arztebl.2016.0301_ref40","unstructured":"G-BA: (last accessed on 12 February 2016)."},{"key":"10.3238\/arztebl.2016.0301_ref41","unstructured":"Gaertner B, Freyer-Adam J, Meyer C, John U: Alkohol \u2013 Zahlen und Fakten zum Konsum. In: DHS (eds): Jahrbuch Sucht 2015, Lengerich: Pabst 2015."},{"key":"10.3238\/arztebl.2016.0301_ref42","doi-asserted-by":"crossref","unstructured":"Pabst A, Kraus L, Matos EGD, Piontek D: Substanzkonsum und substanzbezogene St\u00f6rungen in Deutschland im Jahr 2012. In: DHS (eds): Jahrbuch Sucht 2013, Lengerich: Pabst 2013.","DOI":"10.1024\/0939-5911.a000275"},{"key":"10.3238\/arztebl.2016.0301_ref43","doi-asserted-by":"crossref","unstructured":"John U, Hanke M: Alcohol-attributable mortality in a high per capita consumption country Germany. Alcohol Alcoholism 2002, 37; 581\u20135","DOI":"10.1093\/alcalc\/37.6.581"},{"key":"10.3238\/arztebl.2016.0301_ref44","unstructured":"Effertz T: Die volkswirtschaftlichen Kosten gef\u00e4hrlicher Konsumg\u00fcter \u2013 Eine theoretische und empirische Analyse f\u00fcr Deutschland am Beispiel Alkohol, Tabak und Adipositas. Frankfurt am Main: Peter Lang Verlag 2015."},{"key":"10.3238\/arztebl.2016.0301_ref45","unstructured":"Seitz HK, B\u00fchringer G, Mann K: Grenzwerte f\u00fcr den Konsum alkoholhaltiger Getr\u00e4nke. In: DHS (eds): Jahrbuch Sucht 2008, Geesthacht: Neuland Verlagsgesellschaft mbH 2009."},{"key":"10.3238\/arztebl.2016.0301_ref46","doi-asserted-by":"crossref","unstructured":"DiFranza JR, Guerrera MP. Alcoholism and smoking. J Stud Alcohol. 1990; 51: 130\u20135","DOI":"10.15288\/jsa.1990.51.130"},{"key":"10.3238\/arztebl.2016.0301_ref47","doi-asserted-by":"crossref","unstructured":"Breslau N, Kilbey MM, Andreski P: DSM-III-R nicotine dependence in young adults: prevalence, correlates and associated psychiatric disorders. Addiction. 1994; 89: 743\u201354","DOI":"10.1111\/j.1360-0443.1994.tb00960.x"},{"key":"10.3238\/arztebl.2016.0301_ref48","doi-asserted-by":"crossref","unstructured":"Heinz A, Batra A, Scherbaum N, Gouzoulis-Mayfrank E: Neurobiologie der Abh\u00e4ngigkeit: Grundlagen und Konsequenzen f\u00fcr Diagnose und Therapie von Suchterkrankungen. Stuttgart: Kohlhammer 2012.","DOI":"10.17433\/978-3-17-023564-9"},{"key":"10.3238\/arztebl.2016.0301_ref49","unstructured":"Dilling H, Mombour W: Internationale Klassifikation psychischer St\u00f6rungen: ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien. 8. Aufl., Bern: Huber 2013."},{"key":"10.3238\/arztebl.2016.0301_ref50","unstructured":"Falkai P, Wittchen HU, D\u00f6pfner M: Diagnostisches und Statistisches Manual Psychischer St\u00f6rungen \u2013 DSM-5. G\u00f6ttingen: Hogrefe 2014."},{"key":"10.3238\/arztebl.2016.0301_ref51","doi-asserted-by":"crossref","unstructured":"Maier W, Falkai P, Heinz A: Stellungnahme der Deutschen Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN) Wann wird seelisches Leiden zur Krankheit? Zur Diskussion um das angek\u00fcndigte Diagnosesystem DSM-V. www.dgppn.de\/fileadmin\/user_upload\/_medien\/download\/pdf\/stellungnahmen\/2013\/DGPPN-Stellungnahme_DSM-5_Final.pdf (last accessed on 1 December 2015).","DOI":"10.1007\/s15016-013-0171-6"},{"key":"10.3238\/arztebl.2016.0301_ref52","unstructured":"Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG: The Alcohol Use Disorders Identification Test (AUDIT): Guidelines for use in primary care. Geneva: World Health Organization 2001."},{"key":"10.3238\/arztebl.2016.0301_ref53","doi-asserted-by":"crossref","unstructured":"Levola J, Aalto M: Screening for at-risk drinking in a population reporting symptoms of depression: a validation of the AUDIT, AUDIT-C, and AUDIT-3. Alcohol Clin Exp Res 2015; 39: 1186\u201392","DOI":"10.1111\/acer.12763"},{"key":"10.3238\/arztebl.2016.0301_ref54","unstructured":"Miller WR, Rollnick S: Motivierende Gespr\u00e4chsf\u00fchrung. Freiburg im Breisgau: Lambertus-Verlag (3rd edition) 2015."},{"key":"10.3238\/arztebl.2016.0301_ref55","unstructured":"K\u00f6rkel J: Kontrolliertes Trinken: Vom Abstinenzfundamentalismus zur bedarfsgerechten Behandlungsoptimierung. Sucht aktuell 2001; 8: 16\u201323."},{"key":"10.3238\/arztebl.2016.0301_ref56","doi-asserted-by":"crossref","unstructured":"Stellungnahme der f\u00fcnf Selbsthilfe- und Abstinenzverb\u00e4nde zum Ambulanten Gruppenprogramm zum kontrollierten Trinken (AkT). Sucht 46, 457\u20138.","DOI":"10.1024\/suc.2000.46.6.457"},{"key":"10.3238\/arztebl.2016.0301_ref57","unstructured":"Mann K, Batra A: Community based management of alcohol dependent patients. Evaluation of a combined inpatient and ambulatory treatment concept. Psychiatr Prax 1993; 20: 102\u20135"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T07:00:00Z","timestamp":1693638000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":57,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2016.0301","relation":{"is-cited-by":[{"id-type":"doi","id":"10.1007\/978-3-642-55125-3_32","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]}}}